Hogan Lovells Hires Leading Life Sciences Team in Amsterdam
01 June 2011
AMSTERDAM, 1 JUNE 2011 - Hogan Lovells has expanded its global Life Sciences practice with the recruitment of leading regulatory Life Sciences partner Carla Schoonderbeek and her team of five associates. Carla joins Hogan Lovells International LLP on 1 July 2011.
Carla, until now the head of the Life Sciences group at NautaDutilh, is recognised as one of the leading Life Sciences lawyers in Europe. She has experience in all areas of law relating to the pharmaceutical, biotechnology and medical device sector with extensive litigation experience in regulatory matters, as well as extensive knowledge of EC regulatory affairs, both in respect to EU marketing authorisation procedures and on a national level.
Carla also has broad experience of mergers and acquisitions in the pharmaceutical industry as well as venture capital investments in the biotechnology sector. Her arrival will bring further strength to the firm's global Life Sciences and government regulatory practices as well as the Life Sciences team in the Netherlands.
She brings with her a team of senior lawyers and lawyers, consisting of Bart Jong, Hein van den Bos, Paul Loeb, Ruth Franken and Frederique Reijntjes.
Commenting on Carla's arrival, Co-chief executive David Harris said:
"Our global platform, together with the strength of our life sciences practice, were significant elements in attracting a candidate of Carla’s calibre. We are delighted she has chosen to join us.“
Co-Head of Hogan Lovells Life Sciences practice, Ina Brock:
“Hogan Lovells has one of the market leading Life Sciences practices globally and we are committed to building on our existing capabilities in the Life Sciences sector. Attracting someone of Carla’s market standing is a major boost for us and further strengthens our ability to provide top tier regulatory advice for our Life Sciences clients around the world."
Klaas Bisschop, Office Managing Partner in Amsterdam said:
"Carla is a high profile lawyer in the Dutch and European Life Sciences market. Hogan Lovells in Amsterdam has an outstanding IP and pharma client base, so Carla’s team will be a huge asset to us in the local market as well as internationally."
Carla Schoonderbeek said:
"Hogan Lovells provides me with a global platform to build my practice. I look forward to working with my new colleagues in the Netherlands and internationally and be part of what I believe will be the world's leading Life Sciences practice."
About Hogan Lovells
Hogan Lovells combines the breadth of business-oriented legal advice and high-quality service that clients have come to expect through working with its two founding firms – Hogan & Hartson and Lovells.
"Hogan Lovells" or the "firm" refers to the international legal practice comprising Hogan Lovells International LLP, Hogan Lovells US LLP, Hogan Lovells Worldwide Group (a Swiss Verein), and their affiliated businesses, each of which is a separate legal entity. Hogan Lovells International LLP is a limited liability partnership registered in England and Wales with registered number OC323639. Registered office and principal place of business: Atlantic House, Holborn Viaduct, London EC1A 2FG. Hogan Lovells US LLP is a limited liability partnership registered in the District of Columbia.
The word "partner" is used to refer to a member of Hogan Lovells International LLP or a partner of Hogan Lovells US LLP, or an employee or consultant with equivalent standing and qualifications, and to a partner, member, employee or consultant in any of their affiliated businesses who has equivalent standing. Rankings and quotes from legal directories and other sources may refer to the former firms of Hogan & Hartson LLP and Lovells LLP. Where case studies are included, results achieved do not guarantee similar outcomes for other clients.